Respiratory Insufficiency: Clinical Trials

7 trials for Respiratory Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 withdrawn. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Withdrawn 7
Phase 21Withdrawn 1

Follow Respiratory Insufficiency: new trials by email Literature Review of Respiratory Insufficiency trials Research Report on Respiratory Insufficiency

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nalmefene vs Naloxone for the Treatment of Recurrent Respiratory Depression After Opioid Overdose
Nalmefene Injection, Naloxone Injection - Opioid Overdose, Opiate Overdose
Phase 3WithdrawnUniversity of New Mexico2024-08-262025-02-10
Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia
Methylprednisolone, Heparin - COVID-19
Phase 3WithdrawnD'Or Institute for Research and Education2020-07-202021-08-11
Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
CPM, Placebo - Allergic Rhinitis, Nasal Congestion
Phase 2 / Phase 3WithdrawnLarkin Community Hospital2019-07-302023-10-16
Modafinil Versus Placebo for Hypoactive Delirium in the Critically Ill
Modafinil, Placebo - Delirium, Respiratory Failure
Phase 3WithdrawnBrigham and Women's Hospital2014-01-012016-11-03
Safety Study of Positive Airway Pressure Via a Nasal Mask in Obese Patients
nasal mask and continuous positive airway pressure - Upper Airway Obstruction
Phase 3WithdrawnMassachusetts General Hospital2012-06-012017-01-18
Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis
Group 1, Group 2 - Nasal Congestion, Cough
Phase 3WithdrawnAche Laboratorios Farmaceuticos S.A.2011-08-012017-07-13
Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure
Hattler Respiratory Assist Catheter - Emphysema, Acute Respiratory Distress Syndrome
Phase 3WithdrawnAlung Technologies2005-11-012015-12-29

Narrower conditions

Nasal Obstruction (2)  ·  Airway Obstruction (1)  ·  Asthma (1)  ·  COVID-19 (1)  ·  Common Cold (1)  ·  Cough (1)  ·  Delirium (1)  ·  Drug Overdose (1)  ·  Emphysema (1)  ·  Heart Failure (1)  ·  Hemostatic Disorders (1)  ·  Opiate Overdose (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Respiration Disorders (7)  ·  Respiratory Tract Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Airway Obstruction (2)  ·  Cardiovascular Diseases (2)  ·  Hypersensitivity (2)  ·  Hypersensitivity, Immediate (2)  ·  Immune System Diseases (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Mental Disorders (2)  ·  Nose Diseases (2)  ·  Otorhinolaryngologic Diseases (2)  ·  RNA Virus Infections (2)

Interventions

Chlorpheniramine (1)  ·  Continuous Positive Airway Pressure (1)  ·  Heparin (1)  ·  Methylprednisolone (1)  ·  Modafinil (1)  ·  Naloxone (1)  ·  nalmefene (1)

Sponsors

Ache Laboratorios Farmaceuticos S.A. (1)  ·  Alung Technologies (1)  ·  Brigham and Women's Hospital (1)  ·  D'Or Institute for Research and Education (1)  ·  Larkin Community Hospital (1)  ·  Massachusetts General Hospital (1)  ·  University of New Mexico (1)

Countries

United States (4)  ·  Brazil (1)  ·  United Kingdom (1)

Top investigators

Caitlin Bonney, MD (1)  ·  Eduardo M Rego, MD, PhD (1)  ·  Gerald L Weinhouse, MD (1)  ·  Marcos A Sanchez-Gonzalez (1)  ·  Steven Tsui, MD (1)  ·  Yandong Jiang, MD, PhD (1)

Results publications

PMID 35244208